Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term renal cell. Found 13 abstracts

Haifler M, Ristau BT, Higgins AM, Smaldone MC, Kutikov A, Zisman A, Uzzo RG. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2018 Mar;199(3):649-54.
Haifler M, Ristau BT, Higgins AM, Smaldone MC, Kutikov A, Zisman A, Uzzo RG. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2017 Sep 20;.
Ito T, Derweesh IH, Ginzburg S, Abbosh PH, Raheem OA, Mirheydar H, Hamilton Z, Chen DY, Smaldone MC, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017 Jan;197(1):31-6.
Ito T, Derweesh IH, Ginzburg S, Abbosh PH, Raheem OA, Mirheydar H, Hamilton Z, Chen DY, Smaldone MC, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017 Jan;197(1):31-6.
Minervini A, Campi R, Kutikov A, Montagnani I, Sessa F, Serni S, Raspollini MR, Carini M. Histopathological Validation of the Surface-Intermediate-Base Margin Score for Standardized Reporting of Resection Technique during Nephron Sparing Surgery. J Urol. 2015 Oct;194(4):916-22.
Ginzburg S, Uzzo R, Al-Saleem T, Dulaimi E, Walton J, Corcoran A, Plimack E, Mehrazin R, Tomaszewski J, Viterbo R, Chen DY, Greenberg R, Smaldone M, Kutikov A. Coexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal Biopsy. Journal of Urology. 2014 Feb;191(2):296-300.   PMCID: PMC4083459
Mehrazin R, Smaldone MC, Kutikov A, Li T, Tomaszewski JJ, Canter DJ, Viterbo R, Greenberg RE, Chen DY, Uzzo RG. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol. 2014 Sep;192(3):659-64.   PMCID: 4419692
Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics. 2011 Feb;3(1):19-34.   PMCID: NIHMS362391
Plimack ER, Hudes GR. Selecting Targeted Therapies for Patients With Renal Cell Carcinoma. Journal of the National Comprehensive Cancer Network. 2011 Sep;9(9):997-1007.   PMCID: not NIH funded
Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. Journal of Urology. 2007 Mar;177(3):849-53.
Kunkle DA, Crispen PL, Li TY, Uzzo RG. Tumor size predicts synchronous metastatic renal cell carcinoma: Implications for surveillance of small renal masses. Journal of Urology. 2007 May;177(5):1692-6.
Motzer RJ, Michaelson MD, Rosenberg J, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Wilding G. Sunitinib efficacy against advanced renal cell carcinoma. Journal of Urology. 2007 Nov;178(5):1883-7.
Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RA, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS. Residual and recurrent disease following renal energy ablative therapy: A multi-institutional study. JOURNAL OF UROLOGY. 2006 Nov;176(5):1973-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term renal cell

carcinoma renal cell kidney pathology nephrectomy kidney neoplasms theoretical hemorrhage diagnostic imaging Male Middle Aged CANCER mathematical concepts Kidney Neoplasms tumors Female cell carcinoma aspirin Aged sunitinib models clopidogrel natural history germline mutations Platelet Aggregation Inhibitors translational application Kinetics RCC bladder cancer prevention & control efficacy interferon-alpha features PROGNOSIS methylation Clopidogrel Time Factors STAGE therapy dna methylation cryotherapy parenchymal volume etiology genetics risks surveillance accuracy CELL CARCINOMA Coronary Thrombosis Treatment Outcome Postoperative Hemorrhage percutaneous biopsy Tumor Burden Perioperative Period catheter ablation complications Urology & Nephrology medullary survival masses needle core biopsy oxyphilic cpg-island methylation neoplasm metastasis statistics & numerical data adverse effects Renal Cell Carcinoma prognosis KIDNEY Retrospective Studies radical nephrectomy competing clear-cell SU11248 t1b Blood Transfusion randomized-trial tumor-suppressor gene clear cell renal cell carcinoma NEPHRECTOMY NATURAL-HISTORY gene outcomes non-clear cell renal cell carcinoma evidence-based medicine tumor suppressor gene bevacizumab colorectal-cancer disease progression ENDOTHELIAL GROWTH-FACTOR guided radiofrequency ablation e-cadherin Aspirin renal-cell carcinoma cryoablation aberrant promoter phase-iii trial parameter experience collecting duct carcinoma Watchful Waiting Surgical Blood Loss Nephrectomy watchful waiting growth-factor-beta INHIBITOR DIAMETER Adult Age Factors epidemiology Risk Factors SURVIVAL CLASSIFICATION surgery 80 and over Aged validation studies MANAGEMENT LESS RANDOMIZED-TRIAL INTERFERON-ALPHA clinical-trials FEATURES LESIONS nephron-sparing surgery INTERLEUKIN-2 Patient Readmission active chemotherapy neoplasm staging TUMOR SIZE score THERAPY Neoplasm Staging oncocytoma Carcinoma NEPHRON-SPARING SURGERY radio-frequency ablation methylome observation promoter hypermethylation 2010 dermott df-v28 adenoma
Last updated on Friday, January 03, 2020